Credit Suisse’s La Jolla Pharmaceutical Company LJPC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-10,757
| Closed | -$99K | – | 3596 |
|
|
2019
Q2 | $99K | Sell |
10,757
-4,306
| -29% | -$39.6K | ﹤0.01% | 3306 |
|
|
2019
Q1 | $96K | Sell |
15,063
-574
| -4% | -$3.66K | ﹤0.01% | 3255 |
|
|
2018
Q4 | $147K | Sell |
15,637
-27,909
| -64% | -$262K | ﹤0.01% | 3190 |
|
|
2018
Q3 | $877K | Buy |
43,546
+26,499
| +155% | +$534K | ﹤0.01% | 2505 |
|
|
2018
Q2 | $497K | Buy |
17,047
+10
| +0.1% | +$292 | ﹤0.01% | 2973 |
|
|
2018
Q1 | $507K | Buy |
17,037
+182
| +1% | +$5.42K | ﹤0.01% | 2941 |
|
|
2017
Q4 | $541K | Sell |
16,855
-10,570
| -39% | -$339K | ﹤0.01% | 2910 |
|
|
2017
Q3 | $954K | Sell |
27,425
-4,675
| -15% | -$163K | ﹤0.01% | 2685 |
|
|
2017
Q2 | $956K | Buy |
32,100
+19,017
| +145% | +$566K | ﹤0.01% | 2380 |
|
|
2017
Q1 | $391K | Buy |
+13,083
| New | +$391K | ﹤0.01% | 3059 |
|
|
2016
Q4 | – | Sell |
-11,659
| Closed | -$277K | – | 3941 |
|
|
2016
Q3 | $277K | Sell |
11,659
-21,082
| -64% | -$501K | ﹤0.01% | 3349 |
|
|
2016
Q2 | $524K | Buy |
+32,741
| New | +$524K | ﹤0.01% | 3100 |
|
|
2016
Q1 | – | Sell |
-12,768
| Closed | -$344K | – | 4170 |
|
|
2015
Q4 | $344K | Sell |
12,768
-34,762
| -73% | -$937K | ﹤0.01% | 3396 |
|
|
2015
Q3 | $1.32M | Buy |
+47,530
| New | +$1.32M | ﹤0.01% | 2402 |
|
|
2014
Q2 | – | Sell |
-18,437
| Closed | -$199K | – | 4492 |
|
|
2014
Q1 | $199K | Buy |
+18,437
| New | +$199K | ﹤0.01% | 3979 |
|